Premium Intraocular Lenses (IOLs)

What Are Premium Intraocular Lenses? 

When a patient undergoes cataract surgery or Refractive Lens Exchange (RLE), the eye’s natural lens is removed and replaced with an artificial lens called an intraocular lens, or IOL. Every patient who has one of these procedures receives an IOL — it is a fundamental part of the surgery. 

The question is which IOL. 

A standard monofocal IOL corrects vision at one distance —Patients are not guaranteed to see clearly across a room, while driving, and outdoors, and they will need reading glasses for anything up close and often for computer work as well. For decades, this was the only option available, and it remains the lens covered by most insurance plans. 

Premium IOLs go further. These advanced lenses are engineered to correct vision at multiple distances — near, intermediate, and far — with the goal of reducing or eliminating dependence on glasses for daily activities. Today’s premium IOL technology has advanced to the point where the correct lens, placed by an experienced surgeon, can give patients clearer vision than they have had in years, often at every distance. 

Dr. Jonathan Solomon at Holzman Solomon Vision Partners in lens-based vision correction and offers one of the most comprehensive selections of premium IOL technology available in the Washington, D.C., Maryland, and Northern Virginia region. His approach is simple: understand the patient’s eyes, lifestyle, and visual goals — then match them with the lens that will deliver the best possible outcome. 

Who Benefits from Premium IOLs? 

Premium IOLs are available to two groups of patients, and Dr. Solomon works with both. 

Cataract surgery patients who need their cloudy natural lens removed can choose a premium IOL as their replacement lens. Rather than settling for clear distance vision plus reading glasses, they can invest in a lens that provides a full range of sight. Cataract surgery with a premium IOL turns a medically necessary procedure into an opportunity for true visual transformation. 

Refractive Lens Exchange (RLE) patients are typically adults over 45 to 50 who want to reduce their dependence on glasses or contacts but may not be ideal candidates for LASIK — often because of presbyopia, early lens changes, or high prescriptions. RLE uses the same surgical technique as cataract surgery, replacing the natural lens with a premium IOL before cataracts develop. The added benefit is that patients who choose RLE will never need cataract surgery in the future.

In both cases, the premium IOL is the centerpiece of the outcome. The lens determines what patients see, how clearly they see it, and how much independence from glasses they achieve. That is why lens selection — guided by a surgeon who understands the full range of options — matters enormously. 

The Premium IOL Options Available at Holzman Solomon Vision Partners 

Dr. Solomon offers five distinct premium IOL platforms, each with unique strengths. No single lens is the best choice for every patient. The right lens depends on a patient’s prescription, corneal shape, pupil size, lifestyle priorities, tolerance for visual trade-offs, and how they use their eyes day to day. 

Here is what patients should know about each option. 

PanOptix Pro — Next-Generation Trifocal 

The Clareon PanOptix Pro from Alcon is the newest evolution of the world’s most widely implanted trifocal IOL. Launched in the United States in 2025, PanOptix Pro builds on the proven PanOptix platform with a significant optical upgrade: proprietary ENLIGHTEN NXT technology that achieves 94 percent light utilization — the highest of any trifocal IOL on the market — while cutting light scatter in half compared to the original PanOptix. 

What this means for patients is sharper image contrast, smoother transitions between near, intermediate, and distance vision, and improved visual quality in low-light conditions compared to previous-generation trifocals. 

What to know: More than nine out of ten PanOptix patients report never needing glasses at any distance. The trifocal design means light is split across three focal points, which can produce some nighttime halos — though PanOptix Pro’s reduced scatter makes these less noticeable than with older trifocal designs. Also available in a toric version for patients with astigmatism. 

AcrySof IQ Vivity — Extended Depth of Focus (EDOF) 

The Vivity lens from Alcon takes a fundamentally different approach from trifocal lenses. Rather than splitting light into distinct focal points, Vivity uses a proprietary wavefront-shaping technology called X-WAVE to stretch and shift light, creating an extended, continuous range of focus from distance through intermediate vision. 

The result is excellent distance and intermediate clarity — driving, watching television, working on a computer, checking a phone — with noticeably fewer halos and glare than trifocal lenses. The trade-off is that near vision for very fine print (reading a paperback book, threading a needle) may require light reading glasses. 

What to know: Vivity delivers some of the highest contrast sensitivity of any premium IOL, which translates to crisp, high-definition vision in real-world conditions. Patients who value driving comfort and screen clarity over fine-print reading independence often prefer Vivity. Also available in a toric version for astigmatism correction. 

RxSight Light Adjustable Lens (LAL) — The Only Lens Customizable After Surgery 

The Light Adjustable Lens from RxSight is unlike any other IOL on the market. It is the only FDA-approved lens that can be adjusted after it has been implanted — giving Dr. Solomon the ability to fine-tune a patient’s vision weeks after surgery, once the eye has healed and the prescription has stabilized. 

Here is how it works: The LAL is made from a special photosensitive material. After the lens is implanted and the eye has healed, the patient returns for a series of painless UV light treatments that precisely reshape the lens to optimize the prescription. It is similar to getting a “test drive” of different prescriptions before locking in the final result. 

This adjustability is a significant advantage for patients who want the most precise outcome possible, particularly those with complex visual needs or patients who have had previous vision correction procedures like LASIK. 

What to know: The adjustment process typically involves two to four office visits over several weeks after surgery. During the adjustment period, patients must wear special UV-protective glasses whenever outdoors to prevent unintended changes to the lens. Once the final

prescription is locked in, the lens is permanent. The LAL can be set for distance, monovision (one eye near, one eye far), or a modified extended range. 

EnVista Envy — Trifocal with Intelligent Light Distribution 

The enVista Envy from Bausch + Lomb is a next-generation trifocal IOL that received FDA approval in October 2024. Built on the proven glistening-free enVista platform, the Envy lens introduces ActivSync Optic technology — an intelligent light distribution system that adapts to different lighting conditions. 

In bright light, the lens distributes energy evenly across all three focal points for a full range of clear vision. In dim or low-light conditions, it automatically prioritizes distance vision, improving contrast and reducing glare when patients need it most — such as while driving at night. 

What to know: In clinical trials, 90 percent of patients achieved spectacle independence for near tasks, and 93 percent reported moderate to complete satisfaction with their post-surgical vision. The Envy lens is also available in a toric version for astigmatism correction and has been praised by surgeons for particularly strong performance in patients with medium-to-large pupils. 

FineVision HP — The World’s Original Trifocal, Now in Its Third Generation 

The FineVision HP from BVI is the latest evolution of the lens platform that pioneered trifocal IOL technology in 2010. With over one million FineVision lenses implanted worldwide and more than 15 years of clinical data, this is one of the most proven premium IOL platforms in existence. The HP (hydrophobic) version received FDA approval in October 2025, making it newly available to patients in the United States. 

FineVision HP uses a patented CoPODize technology that combines convolution and apodization across the entire optic zone — engineering terms that translate to smoother light transitions and reduced halos and glare compared to conventional diffractive designs. The lens also features a unique double C-loop haptic design for exceptional rotational stability and precise centration inside the eye. 

What to know: FineVision HP features a glistening-free hydrophobic material designed for long-term optical clarity. The lens provides balanced vision at distance, intermediate (approximately arm’s length), and near focal points. As a recently FDA-approved lens, Dr. Solomon is among the early adopters offering this technology in the Northern Virginia region. 

How Dr. Solomon Selects the Right Lens for Each Patient 

Choosing a premium IOL is not a one-size-fits-all decision. It is a personalized process that Dr. Solomon takes seriously, because the lens implanted today will be in the patient’s eye for the rest of their life. 

The selection process begins with a comprehensive evaluation that goes far beyond a standard eye exam. Dr. Solomon’s diagnostic workup includes precise measurements of the eye’s length, corneal curvature and shape, pupil size in various lighting conditions, retinal health, tear film quality, and any pre-existing conditions that could affect lens performance. 

Beyond the clinical data, the conversation matters just as much. Dr. Solomon asks patients detailed questions about how they use their eyes. A patient who spends eight hours a day on a computer has different needs than a patient who reads for pleasure every evening. A patient who drives long distances at night needs different optical characteristics than a patient whose primary frustration is switching between distance glasses and readers throughout the day. 

This combination of advanced diagnostics and lifestyle-focused conversation allows Dr. Solomon to recommend the lens — or sometimes the combination of lenses — that will deliver the best real-world outcome for each individual patient. 

Understanding the Investment: Cost and Financing 

Premium IOLs represent an investment in long-term visual quality that goes beyond what standard insurance-covered lenses provide. 

For cataract surgery patients, the surgical procedure itself is typically covered by insurance or Medicare. The premium IOL upgrade — the additional cost for advanced lens technology beyond a standard monofocal lens — is an out-of-pocket expense. This upgrade cost covers the lens itself, the advanced diagnostic testing required for premium lens selection, and the additional follow-up care involved in optimizing the outcome. 

For RLE patients, the entire procedure is considered elective and is not covered by insurance, similar to LASIK or other elective vision correction procedures. 

Holzman Laser Vision offers flexible financing options, including CareCredit, to help make premium lens technology accessible. Many patients also use Health Savings Accounts (HSA) or Flexible Spending Accounts (FSA) to cover all or part of the cost. The team discusses all pricing and financing during the consultation, so there are no surprises.

When patients weigh the investment against the alternative — decades of purchasing and replacing glasses and contact lenses — many find that premium IOLs represent significant long-term value, in addition to the daily convenience and quality of life they provide. 

What to Expect: The Procedure and Recovery 

Whether a patient is having cataract surgery or RLE, the surgical process is the same — and it is one of the most commonly performed and well-established procedures in all of medicine. 

The procedure takes approximately 10 to 15 minutes per eye and is performed as an outpatient procedure under local anesthesia with mild sedation. There are no needles in the eye, no stitches, and no general anesthesia. A tiny, self-sealing incision is made, the natural lens is gently removed using ultrasound, and the premium IOL is inserted and positioned precisely inside the eye. 

Eyes are typically treated one at a time, with the second eye scheduled about one to two weeks after the first. Most patients notice clearer vision within the first day or two, with continued improvement over the following weeks as the brain adapts to the new lens — particularly with trifocal designs where neural adaptation plays an important role. 

For patients who choose the Light Adjustable Lens, additional UV light adjustment visits are scheduled in the weeks following surgery to customize the final prescription. 

Dr. Solomon monitors every patient closely through a series of post-operative appointments to ensure healing is progressing well and visual outcomes are on track.